Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$36.76 – $68.00
86% from low
Sector
Asset Management - Global
Exchange
NASDAQ
ETF
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
www.globalxetfs.com/funds/GNOMNo one on the platform currently holds GNOM.
No tracked institution reports a position in GNOM as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-29 | $0.0579 | 2026-07-07 |
| 2025-12-30 | $0.5912 | 2026-01-07 |
| 2025-06-27 | $0.0083 | 2025-07-07 |
| Execution date | Ratio |
|---|---|
| 2025-09-02 | 1-for-4reverse |
No one on the platform has traded GNOM yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| GNOMGlobal X - Genomics & Biotechnology ETF | $63.58 | -0.11% | $93M | — |
| BOATSonicShares Global Shipping ETF | $52.54 | +0.40% | $61M | — |
| CSPFCohen & Steers Preferred and Income Opportunities Active ETF | $25.59 | +0.27% | $47M | — |
| DEMZDemocratic Large Cap Core ETF | $46.95 | -0.12% | $67M | — |
| DVYAiShares Asia/Pacific Dividend ETF | $50.02 | -0.77% | $70M | — |
| HTECROBO Global Healthcare Technology and Innovation ETF | $41.72 | +0.49% | $65M | — |
| HYDRGlobal X - Hydrogen ETF | $43.86 | +0.81% | $100M | — |
Source: Financial Modeling Prep · peers by sector/industry
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.
$ABCL Biotech ETF Breakouts - $GNOM is the Global X Genomics & Biotechnology ETF. It tracks global companies specializing in gene editing, genomic sequencing, and genetic medicine. - $IBB is the iShares Biotechnology ETF. It is one of the oldest and largest funds tracking standard U.S. biotechnology companies. These charts highlight a strong, highly coordinated technical breakout across the sector. Both funds are pushing past multi-year resistance levels following massive consolidation periods. Imo, $ABCL is best positioned to take advantage of these industry-wide breakouts.
View on StockTwits ↗$GNOM has already shown meaningful upside momentum, with the ETF up roughly +20% as capital begins to rotate back into genomics and biotech innovation themes. What the market is starting to price in is not just short-term sector strength, but the longer-term optionality around breakthroughs in gene editing, genomics, and therapeutic applications that could reshape entire healthcare segments. In early-stage thematic cycles like this, price often moves ahead of widely recognized “headline moments,” as positioning builds gradually before major narrative catalysts emerge. The key dynamic is whether this remains a short rotation trade or evolves into a sustained multi-phase sector trend driven by real clinical and commercial progress.
View on StockTwits ↗$GNOM possesses strong structural potential to outperform the S&P 500 over the next few years. While many popular ETFs have rallied hard this year, most are trading near all-time highs (ATHs). In contrast, this genomics and biotech play remains near historical lows (ATLs). Looking forward, this significant valuation reset offers a highly asymmetric risk-reward setup for mean reversion.
View on StockTwits ↗$INO Inovio has patent for HANTA VIRUS $XBI $GNOM $IBB $PBE HTTPS://patents.google.com/patent/US9675684B2/en
View on StockTwits ↗Why Is CRSP Stock Falling Pre-Market Today? $CRSP $ARKG $GNOM https://stocktwits.com/news/equity/markets/why-is-crsp-stock-falling-pre-market-today/cZdopfWRI7T
View on StockTwits ↗Why Did BNTX Stock Tumble 17% Pre-Market Today? $BNTX $GNOM $IDNA https://stocktwits.com/news/equity/markets/why-did-bntx-stock-tumble-pre-market-today/cZdoYZmRIey
View on StockTwits ↗$GNOM Current Stock Price: $46.98 Contracts to trade: $48.0 GNOM May 15 2026 Call Entry: $3.96 Exit: $7.29 ROI: 84% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review $MRNA $IDNA $GNOM https://stocktwits.com/news/equity/markets/moderna-stock-fda-accepts-revised-flu-vaccine-application-for-review/cZR0MwoR4v1
View on StockTwits ↗$GNOM Current Stock Price: $48.22 Contracts to trade: $45 GNOM Jan 16 2026 Call Entry: $0.70 Exit: $1.28 ROI: 83% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.